Alivus Life Sciences Ltd(BSE:ALIVUS)

{{price.price}} INR

{{price.change}}%

：{{price.high}}	：9265	：4.22%	：44.23
：{{price.low}}	：8172656	：19.94%	：1259
：{{price.open}}	：2.36%	：21.64%	：827
：{{price.close}}	：0.89	：11017460000%	：106334060726

-0.61	-3.24	-4.64	-13.09
-3.84	-19.9	17.44	17.44
5.31	4.38	2.82	9265
26889	56677	符号详情：1天涨跌率 2.36	0.2
-3.83	20	1	-35
869	868	917	3830.8
3275.3	40352.72	32195.89	2.94
0.89	-1.31	0.01	2.93
0.12	0.17	830	830
830	369	827	928
949	1078	1335	1259
39.63	44.34	4856270000	5436900000
3104430000	7638460000	11017460000	11.6
12.22	39.52	44.23	7100590000
23718930000	25122600000
			2452330000
	-5923520000	30153560000
191770000	712360000	6527970000	5488510000
24759470000	6013960000	4893260000	4893260000
604450000	36383430000	106334060726	16.22

			20.47
21.64	32.2	43.85	18.86
19.1	26.18	28.26

Alivus Life Sciences Ltd. engages in the provision of development and manufacture of non-commoditized active pharmaceutical ingredients. It operates through the Within India and Outside India geographical segments. Its products focus on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company was founded on June 23, 2011 and is headquartered in Mumbai, India.

： http://www.glenmarklifesciences.com

：Yasir Rawjee

：2011

：Mumbai

：Health technology

：Pharmaceuticals: major